MedTrace Logo

Non Interventional Study of Levofloxacin in Chronic Prostatitis

NCT02711943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-03-17

No results posted yet for this study

Summary

Chronic prostatitis is a common disease in men with the following typical symptoms decreasing the ability to work and quality of life: pain, urination disorders, copulatory dysfunction.

Following study is conducted to study Levofloxacin in chronic prostatitis.

Conditions

  • Chronic Prostatitis

Interventions

DRUG

Levofloxacin 500

Oral levofloxacin (Levolet®) at a dose of 500 mg once a day for 28 days

Sponsors & Collaborators

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • IGOR A KORNEYEV · Acad. I.P. Pavlov First Saint-Petersburg State Medical University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-02-28
Completion
2014-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02711943 on ClinicalTrials.gov